Zeitschrift für Gastroenterologie, Table of Contents Z Gastroenterol 2025; 63(11): 1134-1136DOI: 10.1055/a-2721-2317 Editorial Man ist was man isst! Authors Johann Ockenga Birgit Terjung Recommend Article Abstract Buy Article(opens in new window) Full Text References Literatur 1 Tessier AJ, Wang F, Korat AA. et al. Optimal dietary patterns for healthy aging. Nat Med 2025; 31: 1644-1652 2 Collaborators GBDD. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019; 393: 1958-1972 3 Schafer AC, Boeing H, Gazan R. et al. A methodological framework for deriving the German food-based dietary guidelines 2024: Food groups, nutrient goals, and objective functions. PLoS One 2025; 20: e0313347 4 Willett W, Rockstrom J, Loken B. et al. Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 2019; 393: 447-492 5 Roeb E, Canbay A, Bantel H. et al. Amendment „Neue Nomenklatur zu MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease: metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2024; 62: 1077-1087 6 Sturm A, Atreya R, Bettenworth D. et al. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline. Z Gastroenterol 2024; 62: 1229-1318 7 Pox C. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe,AWMF): S3-Leitlinie Kolorektales Karzinom, Langversion 3.01, 2025, AWMF-Registernummer: 021-007OL. Accessed September 09, 2025 at: https://www.leitlinienprogramm-onkologie.de/leitlinien/kolorektales-karzinom/ 8 Li F, Armet AM, Korpela K. et al. Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation. Cell 2025; 188: 1226-1247 e18 9 Touvier M, da Costa Louzada ML, Mozaffarian D. et al. Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait. BMJ 2023; 383: e075294 10 Geladari EV, Kounatidis D, Christodoulatos GS. et al. Ultra-Processed Foods and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): What Is the Evidence So Far?. Nutrients 2025; 17: 1-18 11 Schuetz P, Seres D, Lobo DN. et al. Management of disease-related malnutrition for patients being treated in hospital. Lancet 2021; 398: 1927-1938 12 Schuetz P, Fehr R, Baechli V. et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet 2019; 393: 2312-2321 13 Wunderle C, Urbach K, Buchmueller L. et al. Biomarkers for individualized nutritional therapy in disease-related malnutrition: a narrative review. Am J Clin Nutr 2025; 122: 671-679
